People

Weiss-276x303
Jeffrey Weiss, PhD, MS
Mount Sinai Health System - Associate Professor, Department of Medicine
Mount Sinai Health System - Director, Hepatitis C Clinical & Research Program in the Division of General Internal Medicine, Icahn School of Medicine
Email: jeffrey.weiss@mountsinai.org
Education
PhD, Clinical Psychology, Northwestern University Medical School
MS, Clinical Psychopharmacology, Fairleigh Dickinson University
BA, Psychology, Stanford University
Research Interests
Adherence, Treatment readiness, HIV, HCV, Linkage to care, Mental health, Substance use, Mindfulness based stress reduction
BIO
Jeffrey Weiss has worked for over 24 years in the US and Europe as a clinical psychologist providing care to persons with infectious diseases and conducting research on how behavioral interventions can improve their quality and length of life. As Director of the Hepatitis C Research and Clinical Programs in the Division of General Internal Medicine at the Icahn School of Medicine at Mount Sinai, he works closely with colleagues from the Divisions of Liver Diseases to improve the care and treatment of HCV patients at their institution, develop innovative tools, and conduct interdisciplinary research. Dr. Weiss and Dr. Perumalswami co-direct the HepCure project (hepcure.org), a web-based tele-education resource to increase the capacity of primary care providers to conduct Hepatitis C treatment and engage patients in the treatment process through a patient app. In collaboration with the NYC Hepatitis C Task Force, he developed the Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C;prepc.org) a structured clinical assessment to evaluate potential barriers to hepatitis C treatment adherence and develop a treatment plan to address them. He is funded by NIMH to study whether a four-session PREP-C based nurse administered intevention can increase rates of HCV treatment initiation among patients with HIV/HCV-co-infection.
Projects
Principal Investigator, Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults. Completed
Principal Investigator, Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection. Completed
Publications

Recent

Hughes TM, Kalicki A, Huxley-Reicher Z, Toribio W, Samuels DL, Weiss JJ, Hersher M, Wang L (2022).
A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic
Substance Abuse, 43 (1), 988-992. doi: 10.1080/08897077.2022.2060426.

Wisnivesky JP, Becker JH, Ankam J, Markowitz SB, Doernberg M, Dickens B, Busse P, Crowley L, Federman A, Katz C, Weiss JJ, Gonzalez A (2022).
The relationship between post-traumatic stress disorder and self-management behaviors in World Trade Center workers with asthma
Journal of Allergy and Clinical Immunology: In Practice, 10 (1), 242-249. doi: 10.1016/j.jaip.2021.08.035. PMCID: PMC8973280.

Dunham K, Giardina M, Kolod B, McBratney E, Medina Blanco P, Riazi F, Tineo-Komatsu K, Toribio W, Wang L, Woods E, Weiss J (2021).
Transitioning clinical care for people who use drugs to telemedicine: Lessons learned one year into the COVID-19 pandemic
Telemedicine and e-Health, 27 (8), 929-933. doi: 10.1089/tmj.2021.0130.

Riazi F, Toribio W, Irani E, Hughes TM, Huxley-Reicher Z, McBratney E, Vu T, Sigel K, Weiss JJ (2021).
Community case study of naloxone distribution by hospital-based harm reduction program for people who use drugs in New York City
Frontiers in Sociology, 6, 619683. doi: 10.3389/fsoc.2021.619683. PMCID: PMC8292929.

Ziff J, Vu T, Dvir D, Riazi F, Toribio W, Oster S, Sigel K, Weiss J (2021).
Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City
Harm Reduction Journal, 18 (1), 38. doi: 10.1186/s12954-021-00486-4. PMCID: PMC8010955.

Dr. Weiss' MyBibliography Profile